WHITTIER TRUST CO - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,494
-16.6%
2890.0%0.00%
Q2 2023$2,991
-4.6%
2890.0%0.00%
Q1 2023$3,135
-3.3%
2890.0%0.00%
Q4 2022$3,242
+8.1%
2890.0%0.00%
Q3 2022$3,0000.0%2890.0%0.00%
Q2 2022$3,0000.0%2890.0%0.00%
Q1 2022$3,0000.0%2890.0%0.00%
Q4 2021$3,000
+50.0%
2890.0%0.00%
Q3 2021$2,000
-50.0%
2890.0%0.00%
Q2 2021$4,000
-33.3%
2890.0%0.00%
Q1 2021$6,000
+20.0%
2890.0%0.00%
Q4 2020$5,000
+25.0%
2890.0%0.00%
Q3 2020$4,000
-33.3%
2890.0%0.00%
Q2 2020$6,000
-14.3%
2890.0%0.00%
Q1 2020$7,0000.0%2890.0%0.00%
Q4 2019$7,000
+16.7%
2890.0%0.00%
Q3 2019$6,000
+20.0%
2890.0%0.00%
Q2 2019$5,000
-54.5%
289
-40.3%
0.00%
Q1 2019$11,000
-8.3%
4840.0%0.00%
Q4 2018$12,000
-25.0%
4840.0%0.00%
Q3 2018$16,000
+45.5%
4840.0%0.00%
Q2 2018$11,000
-8.3%
4840.0%0.00%
Q1 2018$12,0004840.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,269,584$69,497,223,00012.98%
Newtyn Management, LLC 1,375,000$13,145,0003.15%
Chescapmanager LLC 1,166,574$11,152,0001.51%
Baupost Group 13,643,333$130,430,0001.40%
Weiss Asset Management LP 5,412,487$51,743,0001.07%
CM Management, LLC 120,000$1,147,0000.96%
Orbimed Advisors 3,254,713$31,115,0000.50%
King Wealth Management Group 122,000$1,166,0000.23%
Woodline Partners LP 1,326,653$12,683,0000.21%
PDT Partners, LLC 192,701$1,842,0000.16%
View complete list of THERAVANCE BIOPHARMA INC shareholders